Sangamo Therapeutics
SGMO
#8320
Rank
A$0.28 B
Marketcap
$1.37
Share price
-6.61%
Change (1 day)
-12.61%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2024 (TTM): -A$0.21 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$52.29 Million. In 2023 the company made an earning of -A$0.19 Billion, an increase over its 2022 earnings that were of -A$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.21 Billion6.21%
2023 -A$0.19 Billion-40.88%
2022 -A$0.33 Billion9.79%
2021 -A$0.3 Billion41.52%
2020 -A$0.21 Billion23.17%
2019 -A$0.17 Billion36.33%
2018 -A$0.13 Billion36.89%
2017 -A$89.8 Million-22.32%
2016 -A$0.12 Billion54.86%
2015 -A$74.66 Million75.62%
2014 -A$42.51 Million0.13%
2013 -A$42.46 Million
2011 -A$57.08 Million43.66%
2010 -A$39.73 Million28.52%
2009 -A$30.92 Million-23.55%
2008 -A$40.44 Million2.45%
2007 -A$39.47 Million19.5%
2006 -A$33.03 Million50.78%
2005 -A$21.91 Million75%
2004 -A$12.52 Million-33.25%
2003 -A$18.76 Million-62.27%
2002 -A$49.7 Million102.82%
2001 -A$24.51 Million23.21%
2000 -A$19.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.28 B-231.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.38 Billion 75.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.34 B-3,533.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.03 B-1,520.05%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.54 B-1,292.06%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.78 B-13,094.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.62 B-391.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.85 B-11,255.48%๐Ÿ‡บ๐Ÿ‡ธ USA